TABLE 10.
0.5 g TXA IA | 1.0 g TXA IA | 1.5 g TXA IA | 2.0 g TXA IA | 3.0 g TXA IA | Placebo | |
---|---|---|---|---|---|---|
0.5 g TXA IA | 1 | −0.068 (−0.222, 0.049) | −0.048 (−0.276, 0.137) | −0.042 (−0.21, 0.104) | −0.054 (−0.211, 0.068) | 0.234 (0.09, 0.338) |
1.0 g TXA IA | 0.068 (−0.049, 0.222) | 1 | 0.02 (−0.173, 0.207) | 0.025 (−0.113, 0.181) | 0.014 (−0.109, 0.141) | 0.302 (0.206, 0.392) |
1.5 g TXA IA | 0.048 (−0.137, 0.276) | −0.02 (−0.207, 0.173) | 1 | 0.006 (−0.201, 0.234) | −0.006 (−0.2, 0.197) | 0.282 (0.116, 0.447) |
2.0 gTXA IA | 0.042 (−0.104, 0.21) | −0.025 (−0.181, 0.113) | −0.006 (−0.234, 0.201) | 1 | −0.012 (−0.169, 0.132) | 0.277 (0.123, 0.407) |
3.0 g TXA IA | 0.054 (−0.068, 0.211) | −0.014 (−0.141, 0.109) | 0.006 (−0.197, 0.2) | 0.012 (−0.132, 0.169) | 1 | 0.289 (0.174, 0.391) |
Placebo | −0.234 (−0.338, −0.09) | −0.302 (−0.392, −0.206) | −0.282 (−0.447, −0.116) | −0.277 (−0.407, −0.123) | −0.289 (−0.391, −0.174) | 1 |
Note: Bold results mean statistically significance.
Abbreviations: IA, intra‐articular; TXA, tranexamic acid; EACA, aminocaproic acid.